This research, which investigates a set of fundamental relationships in the R&D literature, is based on an unusually rich set of panel data covering the population of China's large and medium-size manufacturing enterprises. Using a recursive three-equation system, we investigate the determinants of firm-level R&D intensity, the process of knowledge production, and the impact of innovation on firm performance. Several results stand out. Overall, the statistical relationships within the model are surprisingly robust, including the contributions of R&D expenditure to new product (NP) innovation, productivity, and profitability. The roles of firm size, market concentration, and profitability in driving R&D effort parallel to those found in the US literature. We find that new product (NP) innovation accounts for approximately 12% of the total returns to R&D. Also, returns to industrial R&D in China appear to be at least three to four times the returns to fixed production assets.Innovation, R&D, Chinese industry, Productivity,
This paper begins by using a structure-conduct-performance perspective to show that partial reform improved the operation of China's state industries during the 1980s. The authors review the achievements of industries outside the state sector, emphasizing their links to the state sector. The paper focuses on key defects in the industrial system related to finance and ownership; shows how the accelerated reform agenda of the 1980s seeks to resolve these issues; and conclude that China's recent industrial experience demonstrates the feasibility of multiple approaches, including partial and gradual reforms, to the restructuring of industry in former socialist economies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.